iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Pseudogout (CPPD)

Pseudogout (CPPD)

Management of Calcium Pyrophosphate Deposition disease.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
Rheumatology

Clinical Guidelines

Guidelines for this topic are currently being curated. Please check back soon.

Recent iatroX Q&As

  • What are the key clinical features that differentiate pseudogout from gout in a patient presenting with acute joint pain?Updated: 8/17/2025
  • Which investigations should be performed to confirm a diagnosis of calcium pyrophosphate deposition disease (CPPD) in a suspected case?Updated: 8/17/2025
  • What are the recommended first-line treatments for managing an acute attack of pseudogout in primary care?Updated: 8/17/2025
  • When should I consider referring a patient with pseudogout to a rheumatologist for further evaluation and management?Updated: 8/17/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play